Home Cart 0 Sign in  

[ CAS No. 1003-29-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1003-29-8
Chemical Structure| 1003-29-8
Structure of 1003-29-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1003-29-8 ]

Related Doc. of [ 1003-29-8 ]

Alternatived Products of [ 1003-29-8 ]

Product Details of [ 1003-29-8 ]

CAS No. :1003-29-8 MDL No. :MFCD00005217
Formula : C5H5NO Boiling Point : -
Linear Structure Formula :- InChI Key :ZSKGQVFRTSEPJT-UHFFFAOYSA-N
M.W : 95.10 Pubchem ID :13854
Synonyms :

Calculated chemistry of [ 1003-29-8 ]

Physicochemical Properties

Num. heavy atoms : 7
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 26.18
TPSA : 32.86 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.52 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.96
Log Po/w (XLOGP3) : 0.51
Log Po/w (WLOGP) : 0.83
Log Po/w (MLOGP) : -0.56
Log Po/w (SILICOS-IT) : 1.61
Consensus Log Po/w : 0.67

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.21
Solubility : 5.82 mg/ml ; 0.0612 mol/l
Class : Very soluble
Log S (Ali) : -0.77
Solubility : 16.1 mg/ml ; 0.17 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.47
Solubility : 3.24 mg/ml ; 0.034 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 1003-29-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1003-29-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1003-29-8 ]
  • Downstream synthetic route of [ 1003-29-8 ]

[ 1003-29-8 ] Synthesis Path-Upstream   1~21

  • 1
  • [ 1003-29-8 ]
  • [ 39604-60-9 ]
  • [ 937-27-9 ]
Reference: [1] Patent: US2003/212113, 2003, A1,
[2] Patent: US2002/37856, 2002, A1,
  • 2
  • [ 1003-29-8 ]
  • [ 1192-79-6 ]
Reference: [1] Organic Letters, 2006, vol. 8, # 21, p. 4951 - 4954
[2] Tetrahedron, 1993, vol. 49, # 7, p. 1343 - 1350
[3] Tetrahedron Letters, 1988, vol. 29, # 7, p. 777 - 780
[4] Tetrahedron Letters, 1988, vol. 29, # 7, p. 777 - 780
  • 3
  • [ 1003-29-8 ]
  • [ 274-45-3 ]
Reference: [1] Journal of the American Chemical Society, 1955, vol. 77, p. 6353
  • 4
  • [ 1003-29-8 ]
  • [ 271-29-4 ]
Reference: [1] Journal of the American Chemical Society, 1955, vol. 77, p. 6353
[2] Journal of the American Chemical Society, 1955, vol. 77, p. 6353
  • 5
  • [ 1003-29-8 ]
  • [ 1193-62-0 ]
Reference: [1] Tetrahedron Letters, 2002, vol. 43, # 14, p. 2589 - 2592
  • 6
  • [ 1003-29-8 ]
  • [ 408309-29-5 ]
Reference: [1] Patent: WO2009/139834, 2009, A1,
  • 7
  • [ 1003-29-8 ]
  • [ 7732-18-5 ]
  • [ 7726-95-6 ]
  • [ 1122-10-7 ]
Reference: [1] Chemische Berichte, 1925, vol. 58, p. 67
  • 8
  • [ 1003-29-8 ]
  • [ 69917-80-2 ]
Reference: [1] Tetrahedron, 2013, vol. 69, # 39, p. 8527 - 8533
[2] Organic and Biomolecular Chemistry, 2017, vol. 15, # 14, p. 3013 - 3024
[3] Journal of the American Chemical Society, 2017, vol. 139, # 44, p. 15801 - 15811
[4] Chemistry - A European Journal, 2018, vol. 24, # 19, p. 4957 - 4966
[5] Patent: WO2018/53353, 2018, A1,
  • 9
  • [ 1003-29-8 ]
  • [ 69807-81-4 ]
Reference: [1] European Journal of Medicinal Chemistry, 2016, vol. 112, p. 217 - 230
  • 10
  • [ 1003-29-8 ]
  • [ 1197-13-3 ]
Reference: [1] Tetrahedron Letters, 2002, vol. 43, # 14, p. 2589 - 2592
[2] Tetrahedron Letters, 1988, vol. 29, # 7, p. 777 - 780
  • 11
  • [ 64435-30-9 ]
  • [ 79-22-1 ]
  • [ 1003-29-8 ]
  • [ 1197-13-3 ]
Reference: [1] Tetrahedron Letters, 1988, vol. 29, # 7, p. 777 - 780
  • 12
  • [ 1003-29-8 ]
  • [ 931-33-9 ]
YieldReaction ConditionsOperation in experiment
73% at 50℃; for 2 h; General procedure: In a round-bottomed flask, the substrate (1 mmol) and aqueous HBr(48percent) (1 mL) were mixed in DMSO (1 mL). The mixture was stirredat corresponding temperature for 1–4 h. After cooling to roomtemperature, the reaction was adjusted to pH 7–8 with aqueous NaOHsolution (4 M). Then the mixture was washed twice with EtOAc, andthe combined organic extracts were dried, filtered and concentratedunder reduced pressure to give bromination products.
61% With N-Bromosuccinimide In acetonitrile at 0℃; for 0.25 h; 4-Bromo-1 H-pyrrole-2-carboxaldehyde (41). To a stirred solution of 1 H-pyrrole-2- carboxaldehyde 40 (1 g, 10.52 mmol) in CH3CN (10 mL) at 0°C was added N- bromosuccinimide (1 .872 g, 10.52 mmol) and the solution was stirred at 0°C for 15 minutes. Water was added and the resulting mixture was extracted with Et20. Organic layers were dried over anhydrous Na2S04 and concentrated in vacuo. Crystallization of the crude mixture using cyclohexane/ethanol afforded compound 41 as white crystals (1 .125 g, 61 percent): f?f=0.22 (CH2CI2); mp: 121 -122 °C; 1 H NMR (400 MHz, [D6]DMSO): 5=7.12 (m, 1 H), 7.41 (m, 1 H), 9.48 (s, 1 H), 12.51 ppm (bs, 1 H); 13C NMR (100 MHz, [D6]DMSO): 5=97.0, 120.8, 126.5, 132.9, 179.1 ppm; IR (KBr): v=3238, 3108, 2926, 2860, 1655, 1380, 1357, 1 147, 1 104, 920, 827, 771 , 744, 598 cm 1 ; MS (ESI) m/z 173.9-175.9 [M+H]+.
55% With N-Bromosuccinimide In tetrahydrofuran at -78℃; for 1 h; The synthesis of an 8-bromo-substituted Western half is shown in Scheme 5. Treatment of pyrrole-2-carobxaldehyde with one molar equivalent of NBS at -78 °C gave 4-bromopyrrole-2-carboxaldehyde 17 (Anderson, J. H.; Lee, S.-F. Can. J. Chem. 1965, 43, 409-414) in 55percent yield after crystallization. This method of bromination of pyrrole-2-carboxaldehyde is superior to a reported method that uses Br2 (Anderson, J. H.; Lee, S.-F. Can. J. Chem. 1965, 43, 409-414). It should be mentioned here that careful handing of the crude product is required: the off-white solid often turns reddish (irrespective of preparation using Br2 or NBS), which complicates crystallization. Following a procedure for the synthesis of 2-(2-nitroethyl)pyrroles (Taniguchi, M. et al., J. Org. Chem. 2001, 66, 7342-7354), treatment of 17 with <n="92"/>excess nitromethane, sodium acetate and methylamine hydrochloride at room temperature for 16 h followed by reduction of the reaction mixture with NaBH4 gave 4-bromo-2-(2-nitroethyl)pyrrole (18) in variable yields (32-48percent). However, 18 was found to explode (CAUTION), which caused us to avoid handling this compound. Thus, we considered protection of the pyrrole nitrogen in 4-bromo-pyrrole-2- carboxaldehyde (17) for two purposes: (1) to render 4-bromo-2-(2-nitroethyl)pyrrole (18) as a stable compound, and (2) for efficient palladium-coupling in the latter part of the 8-ethynyl Western half synthesis. Considering the facile conditions for removal of a /j-toluenesulfonyl group coupled with the crystalline nature of 2-(2- nitroethyl)-W-/>-tosylpyrroles, λf-tosylation (Tietze, L. F. et al., Synthesis 1996, 851- 857) of compound 17 was carried out. Thus, treatment of 17 with NaH at 0 0C for 1 h followed by quenching with /?-toluenesulfonyl chloride gave 17-Ts as a pale yellow crystalline solid in 68percent yield. Following a reported procedure .for the synthesis of 2- (2-nitrovinyl)-iV-p-tosylpyrroles (Hamdan, A.; Wasley, J. W. F. Synth. Comrhun. 1985, 15, 71-74), a mixture of 17-Ts, excess nitromethane and ammonium acetate was refluxed for 3 h. The crude product was satisfactorily pure as evidenced by NMR spectroscopy and was directly used in the next step. NaBH4 reduction of the crude product in the presence of Montmorillonite KlO (Bahulayan, D. et al., J. Org. Chem. 2003, 68, 5735-5738), or silica gel (Ptaszek, M. et al., Org. Process Res. Dev. 2005, 9, 651-659) at room temperature afforded 2-(2-nitroethyl)-iV-/7-tosylpyrrole 18-Ts as a white solid in 40percent or 58percent yield, respectively. Michael addition of 18-Ts with mesityl oxide in the presence of TBAF (Battersby, A. R. et al., J. Chem. Soc, Perkin Trans. 1 1984, 2725-2732) and 3A molecular sieves gave the detosylated pyrrole- hexanone 19 in 47percent yield. The /?-toluenesulfonyl group is known to be cleaved by TBAF (Yasuhara,.A.; Sakamoto, T. Tetrahedron Lett. 1998, 39, 595-596). Reduction (Ptaszek, M. et al., Org. Process Res. Dev. 2005, 9, 651-659) of 19 with excess zinc dust and HCOONH4 in THF at room temperature gave the 8-bromo Western half 20 in 45percent yield. ; 4-Bromopyrrole-2-carboxaldehyde (17). A solution of pyrrole-2- carboxaldehyde (4.75 g, 50.0 mmol) in dry THF (200 mL) was cooled to -78 0C under argon. NBS (8.90 g, 50.0 mmol) was added and the reaction mixture was stirred for 1 h at -78 0C. Hexanes and water were added and the reaction mixture was allowed to warm to 0 0C. The organic phase was extracted with hexanes and dried (Na2 SO4). Crystallization of the crude mixture using hexanes/THF afforded white crystals (4.83 g, 55percent): mp 120-121 0C [lit. 122-123 0C (Anderson, J. H.; Lee, S.-F. Can. J. Chem. 1965, 43, 409-414)]; 1H NMR δ 6.95 (m, IH), 7.12 (m, IH), 9.45 (s, IH), 9.65-9.85 (br s, IH); 13C NMR δ 99.0, 123.0, 127.0, 132.8, 179.3. Anal. Calcd for C5H4BrNO: C, 34.51; H, 2.32; N, 8.05; Found: C, 34.50; H, 2.26; N, 7.75.
54% With N-Bromosuccinimide In tetrahydrofuran at -78℃; for 1 h; To a 100 mL 3-neck RB flask charged with 1H-pyrrole-2-carbaldehyde (1.0 g, 10.5 mmol) in THF(20 mL) at -78°C, NBS (1.87 g, 10.53 mmol) in THF(20 mL) was addedslowly and thenthe flaskw as maintained at the same temperature for 1 h. The reaction mixture was diluted with hexane and water mixture, the organic layer was decanted. The organic layer was dried over anhydrous Na2SO4 and then concentrated at low temperature under vacuo. It was recrystallized with n-hexane to yield the title compound (1 .0 g, 54.0percent) as a pale pink solid.
53% With N-Bromosuccinimide In tetrahydrofuran at -78℃; 1H-Pyrrole-2-carbaldehyde (20g, 210mmol) was dissolved in 250ml tetrahydrofuran and the mixture was cooled to−78°C. N-Bromosuccinimide (37g, 210mmol) was added portion-wise over 1h with stirring and the mixture was stirred for a further 6.5at−78°C. The mixture was allowed to warm to 0°C and was partitioned between water and hexane and protected from the light. The aqueous phase was extracted with cold hexane and the combined organics were washed with water, dried over anhydrous sodium sulphate and filtered. The organics were concentrated under reduced pressure until a precipitate formed. The solid was cold-filtered, washed with cold hexane and dried under vacuum to give 12.8g of 80. The filtrates were concentrated again under reduced pressure until further precipitate formed. This was collected by filtration as before and combined with the first obtained solid to give 80 (18.9g, 109mmol, 53percent yield). Purity 96percent. Stored at 4°C in the dark. 1H NMR (400MHz, CDCl3) δ ppm 6.96–6.99 (m, 1H, H-3), 7.11–7.14 (m, 1H, H-5), 9.47 (s, 1H, CHO), 9.88 (br. s., 1H, NH). UPLC/MS (3min) retention time 1.18min. LRMS: m/z 172, 174 (M−1).
51% With N-Bromosuccinimide In tetrahydrofuran at 0℃; for 0.25 h; Inert atmosphere 4.3.5
4-Bromopyrrole-2-carboxaldehyde (13)
A solution of pyrrole-2-carboxaldehyde 12 (3.80 g, 40 mmol) in dry THF (40 mL) was cooled to 0 °C under Argon. NBS (7.12 g, 40 mmol) was added and the reaction mixture stirred for 15 min before the solvent was removed in vacuo.
The crude product was dried under high vacuum for 30 min before the addition of distilled water (20 mL) and the resulting suspension filtered.
The resulting solid was dissolved in a minimum amount of hot ethanol/water solution (9:1) before the addition of activated charcoal and filtration through a Celite plug.
Upon cooling, the product recrystallised to give 4-bromopyrrole-2-carboxaldehyde 13 (3.54 g, 51percent) as an off white solid; Mp 119-122 °C. IR (neat, cm-1) 3204, 3108, 3982, 2861, 1653, 1378, 1354, 918, 769. 1H NMR (400 MHz, Acetone-d6) δ 11.39 (1 H, s, NH), 9.52 (1 H, d, 4JHH 1.0, CHO), 7.34-7.31 (1 H, m, C5H), 7.09-7.05 (1 H, m, C3H).
13C NMR (101 MHz, Acetone-d6) δ 179.4 (s, C=O), 134.3 (s, C2), 126.8 (s, C5), 121.5 (s, C3), 98.4 (s, C4). HRMS (ESI) m/z calcd for [M+H]+ C5H4BrNO 173.9554; found 173.9553.

Reference: [1] Organic Letters, 2015, vol. 17, # 8, p. 1822 - 1825
[2] Journal of Medicinal Chemistry, 2015, vol. 58, # 18, p. 7286 - 7309
[3] Journal of Chemical Research, 2014, vol. 38, # 10, p. 593 - 596
[4] Patent: WO2017/20944, 2017, A1, . Location in patent: Page/Page column 32
[5] Journal of Organic Chemistry, 2006, vol. 71, # 11, p. 4092 - 4102
[6] Patent: WO2007/64842, 2007, A2, . Location in patent: Page/Page column 89-91; 104
[7] Patent: WO2014/202528, 2014, A1, . Location in patent: Page/Page column 78
[8] European Journal of Medicinal Chemistry, 2016, vol. 113, p. 102 - 133
[9] Tetrahedron, 2016, vol. 72, # 19, p. 2456 - 2463
[10] Journal of Organic Chemistry, 2017, vol. 82, # 18, p. 9350 - 9359
[11] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1986, vol. 22, # 7, p. 806 - 807[12] Khimiya Geterotsiklicheskikh Soedinenii, 1986, vol. 22, # 7, p. 998 - 999
[13] European Journal of Medicinal Chemistry, 2018, vol. 152, p. 235 - 252
  • 13
  • [ 1003-29-8 ]
  • [ 33515-62-7 ]
YieldReaction ConditionsOperation in experiment
81% With N-iodo-succinimide In tetrahydrofuran at -75℃; for 2.33333 h; A solution of lH-pyrrole-2-carbaldehyde (7.0 g, 73.6 mmol) in tetrahydrofuran (45 mL) was cooled to -750C. N-iodosuccinimide (19.8 g, 88.3 mmol) was added portionwise over 20 min and the reaction mixture was then stirred for 2 h at -75 °C. Water and petroleum ether were added and the reaction mixture warmed to ambient temperature. The organic layer was separated and the aqueous phase extracted with petroleum ether. The combined organic layers were washed with water, brine, dried over anhydrous sodium sulfate, filtered and concentrated in vacuo to afford 4-iodo-lH- pyrrole-2-carbaldehyde (13.2 g, 81percent) as a black solid.
Reference: [1] Patent: WO2009/130481, 2009, A1, . Location in patent: Page/Page column 107
[2] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 24, p. 4515 - 4518
  • 14
  • [ 1003-29-8 ]
  • [ 2999-46-4 ]
  • [ 107407-80-7 ]
YieldReaction ConditionsOperation in experiment
97.3% With 1,8-diazabicyclo[5.4.0]undec-7-ene In dichloromethane for 3 h; Reflux To a solution of 1H-pyrrole-2-carbaldehyde (9.51 g, 100.0 mmol, 1.0 eq) in DCM (150.0 mL) was added DBU (15.2 g, 100.0 mmol, 1.0 eq), followed by ethyl 2-isocyanoacetate (11.3 g, 100.0 mmol, 1.0 eq). The resulting mixture was heated to refluxed for 3 h, then 10percent AcOH (250 mL), and separated, the organic phase was washed with water (100 mL x 2), dried over anhydrous MgSO4, filtrated and concentrated. The residue was purified by column chromatography (PE/EA=4/1, vlv) to afford ethyl pyrrolo[1,2-cjpyrimidine-3-carboxylate as a yellow solid (18.5 g, 97.3percent).
61% With 1,8-diazabicyclo[5.4.0]undec-7-ene In tetrahydrofuran at 20℃; [1114] A solution of pyrrole-2-carboxaldehyde (3.6 g, 38.1 mmol) in 40 mL dry THF is added to ethyl isocyanoacetate (4.3 g, 38.1 mmol) and DBU (5.8 g, 38.2 mmol) in 60 mL dry THF. After stirring at RT overnight, the reaction is neutralized with 10percent AcOH. The solvent is removed in vacuo. The residue is taken up in EtOAc/H2O, the aqueous layer is extracted with EtOAc, dried (MgSO4), filtered and concentrated. The residue is purified by flash chromatography on silica gel eluting with 30-70percent EtOAc/hexanes. The carboxylate is obtained (4.45 g, 61percent) as an off-white solid. 1H NMR (400 MHz, CDCl3) δ 8.86, 8.24, 7.54, 7.01, 6.78, 4.45, 1.44.
Reference: [1] Patent: WO2018/35061, 2018, A1, . Location in patent: Paragraph 0448
[2] Organic and Biomolecular Chemistry, 2015, vol. 13, # 14, p. 4231 - 4239
[3] Patent: US2003/236264, 2003, A1, . Location in patent: Page 49
[4] Tetrahedron Letters, 1996, vol. 37, # 24, p. 4263 - 4266
  • 15
  • [ 1003-29-8 ]
  • [ 105-56-6 ]
  • [ 107407-80-7 ]
Reference: [1] Journal of Organic Chemistry, 1999, vol. 64, # 21, p. 7788 - 7801
  • 16
  • [ 1003-29-8 ]
  • [ 159326-69-9 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1994, vol. 31, # 4, p. 781 - 786
[2] Patent: WO2016/190847, 2016, A1,
[3] Patent: CN104876935, 2017, B,
[4] Patent: CN104974163, 2017, B,
  • 17
  • [ 1003-29-8 ]
  • [ 159326-68-8 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1994, vol. 31, # 4, p. 781 - 786
[2] Journal of Heterocyclic Chemistry, 1994, vol. 31, # 4, p. 781 - 786
  • 18
  • [ 1003-29-8 ]
  • [ 159326-71-3 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1994, vol. 31, # 4, p. 781 - 786
[2] Patent: WO2009/117157, 2009, A1,
  • 19
  • [ 1003-29-8 ]
  • [ 263382-27-0 ]
Reference: [1] Tetrahedron Letters, 2002, vol. 43, # 14, p. 2589 - 2592
  • 20
  • [ 1003-29-8 ]
  • [ 918538-04-2 ]
Reference: [1] Patent: WO2016/190847, 2016, A1,
[2] Patent: CN104974163, 2017, B,
  • 21
  • [ 1003-29-8 ]
  • [ 918538-05-3 ]
Reference: [1] Patent: WO2016/190847, 2016, A1,
[2] Patent: CN104876935, 2017, B,
[3] Patent: CN104974163, 2017, B,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1003-29-8 ]

Aldehydes

Chemical Structure| 1192-79-6

[ 1192-79-6 ]

5-Methylpyrrole-2-carbaldehyde

Similarity: 0.96

Chemical Structure| 1192-58-1

[ 1192-58-1 ]

1-Methylpyrrole-2-carboxaldehyde

Similarity: 0.90

Chemical Structure| 67350-50-9

[ 67350-50-9 ]

5-(Hydroxymethyl)-1H-pyrrole-2-carbaldehyde

Similarity: 0.77

Chemical Structure| 2199-58-8

[ 2199-58-8 ]

3,5-Dimethyl-1H-pyrrole-2-carbaldehyde

Similarity: 0.75

Chemical Structure| 931-33-9

[ 931-33-9 ]

4-Bromo-1H-pyrrole-2-carbaldehyde

Similarity: 0.71

Related Parent Nucleus of
[ 1003-29-8 ]

Pyrroles

Chemical Structure| 1192-79-6

[ 1192-79-6 ]

5-Methylpyrrole-2-carbaldehyde

Similarity: 0.96

Chemical Structure| 1192-58-1

[ 1192-58-1 ]

1-Methylpyrrole-2-carboxaldehyde

Similarity: 0.90

Chemical Structure| 636-41-9

[ 636-41-9 ]

2-Methyl-1H-pyrrole

Similarity: 0.78

Chemical Structure| 67350-50-9

[ 67350-50-9 ]

5-(Hydroxymethyl)-1H-pyrrole-2-carbaldehyde

Similarity: 0.77

Chemical Structure| 1072-83-9

[ 1072-83-9 ]

1-(1H-Pyrrol-2-yl)ethanone

Similarity: 0.75